---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-055089"
form_type: "8-K"
ticker: "DTIL"
cik: "0001357874"
company_name: "PRECISION BIOSCIENCES INC"
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T09:07:54.698024+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Precision BioSciences sells 25,000 shares at $12 to management in private placement

## Summary
- Gross proceeds ~$300k from sale of 25,000 shares at $12.00/share (13.5% premium to prior day close).
- CEO Michael Amoroso and CFO Alex Kelly each purchase 8,334 shares ($100k); GC and CRO purchase 833 shares each.
- Net proceeds to be used to fund ongoing research and development initiatives; close expected May 8, 2024.

## SEC filing metadata
- accession: 0000950170-24-055089
- form_type: 8-K
- ticker: DTIL
- cik: 0001357874
- company_name: PRECISION BIOSCIENCES INC
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357874/000095017024055089/0000950170-24-055089-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357874/000095017024055089/dtil-20240508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-055089
- JSON: https://secwatch.observer/filing/0000950170-24-055089.json
- Plain text: https://secwatch.observer/filing/0000950170-24-055089.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.